Asger provides advanced expertise within health economics and pricing and reimbursement processes in several countries.
Prior to founding NHTA, Asger Lindvig was a Senior Health Economist at Amgros, supporting the Danish Medicines Council with health economic appraisals, price negotiations and decision recommendations. He has been involved in the development of the Danish Medicines Council and the underlying processes from the beginning and was the main driver in developing the guidelines for health economic analyses for new medicines and indications in the hospital sector in Denmark. He is a specialist in pricing and reimbursement, and during his time in Amgros he was responsible for several projects on the topic, including country comparisons of pricing- and reimbursement systems and medicine prices. He is also an expert in innovative pricing agreements, such as managed entry agreements, developing multiple projects on the topic, and was involved in implementing such agreements in the Danish hospital sector.
Asger holds a Msc in Medical Market Access and a BSc in Medicine with Industrial Specialization from Aalborg University, Denmark.